 Ajanta Pharma has target of Rs 165: GujralPublished on Thu, Jan 21, 2010 at 08:55 | Source : CNBC-TV18 Updated at Thu, Jan 21, 2010 at 09:58 3295 Investors following Ajanta Pharma. Share this News with them.
Ajanta Pharma has target of Rs 165, says Technical Analyst, Ashwani Gujral . Gujral told CNBC-TV18, "The smaller pharmaceutical stocks tend to do better when the market is kind of choppy. So we could buy Ajanta Pharma with a stoploss of Rs 125. It had a breakout yesterday; it could see targets of Rs 165." Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stocks/sector.
PREVIOUS STORY Trending NewsBusiness News |
News    Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)  The latest earning numbers FIRST on CNBC-TV18
Videos
Interviews
 May 27 2012, 11:52 | Source: CNBC-TV18  May 27 2012, 11:00 | Source: CNBC-TV18  Subscribe to Moneycontrol Newsletters |
|||||||
